-
1
-
-
15944410609
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
-
LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435.
-
(2005)
N Engl J Med
, vol.352
, pp. 1425-1435
-
-
Larosa, J.C.1
Grundy, S.M.2
Waters, D.D.3
Shear, C.4
Barter, P.5
Fruchart, J.C.6
-
2
-
-
33748952489
-
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial
-
Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial. Lancet 2006; 368: 1155-1163.
-
(2006)
Lancet
, vol.368
, pp. 1155-1163
-
-
Nakamura, H.1
Arakawa, K.2
Itakura, H.3
Kitabatake, A.4
Goto, Y.5
Toyota, T.6
-
3
-
-
79953662888
-
Impact of low density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention
-
Matsumoto I, Miyake Y, Mizukawa M, Takagi Y. Impact of low density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention. Circ J 2011; 75: 905-910.
-
(2011)
Circ J
, vol.75
, pp. 905-910
-
-
Matsumoto, I.1
Miyake, Y.2
Mizukawa, M.3
Takagi, Y.4
-
4
-
-
84861594738
-
Intensity of statin therapy, achieved LDL-C levels and cardiovascular outcomes in Japanese patients after coronary revascularization: Perspectives from the CREDO-Kyoto Registry Cohort-2
-
On behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators
-
Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, et al. On behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Intensity of statin therapy, achieved LDL-C levels and cardiovascular outcomes in Japanese patients after coronary revascularization: Perspectives from the CREDO-Kyoto Registry Cohort-2. Circ J 2012; 76: 1369-1379.
-
(2012)
Circ J
, vol.76
, pp. 1369-1379
-
-
Natsuaki, M.1
Furukawa, Y.2
Morimoto, T.3
Nakagawa, Y.4
Ono, K.5
Kaburagi, S.6
-
5
-
-
33645737679
-
Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese
-
Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, et al. Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese. Am J Cardiol 2006; 97: 1165-1171.
-
(2006)
Am J Cardiol
, vol.97
, pp. 1165-1171
-
-
Sakamoto, T.1
Kojima, S.2
Ogawa, H.3
Shimomura, H.4
Kimura, K.5
Ogata, Y.6
-
6
-
-
39849090518
-
Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: The OACISLIPID Study
-
Sato H, Kinjo K, Ito H, Hirayama A, Nanto H, Fukunami M, et al. Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: The OACISLIPID Study. Circ J 2008; 72: 17-22.
-
(2008)
Circ J
, vol.72
, pp. 17-22
-
-
Sato, H.1
Kinjo, K.2
Ito, H.3
Hirayama, A.4
Nanto, H.5
Fukunami, M.6
-
7
-
-
77955085510
-
Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease: LDL-cholesterol: The lower, the better; is it true for Asians?
-
Miyauchi K, Daida H. Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease: LDL-cholesterol: The lower, the better; is it true for Asians? (Pro) Circ J 2010; 74: 1718-1730.
-
(2010)
Pro Circ J
, vol.74
, pp. 1718-1730
-
-
Miyauchi, K.1
Daida, H.2
-
8
-
-
77955074057
-
Just make it lower is an alternative strategy of lipid-lowering therapy with statins in Japanese patients: LDL cholesterol: The lower, the better; is it true for Asians?
-
Sakamoto T, Ogawa H. "Just make it lower" is an alternative strategy of lipid-lowering therapy with statins in Japanese patients: LDL cholesterol: The lower, the better; is it true for Asians? (Con) Circ J 2010; 74: 1731-1741.
-
(2010)
Con Circ J
, vol.74
, pp. 1731-1741
-
-
Sakamoto, T.1
Ogawa, H.2
-
9
-
-
80052139677
-
Intensively loweringboth low-density lipoprotein cholesterol and blood pressure dose not reduce cardiovascular risk in Japanese coronary artery disease patients
-
On behalf of the JCADII Investigators
-
Kohro T, Yamazaki T, Izumi T, Daida H, Kurabayashi M, Miyauchi K, et al. On behalf of the JCADII Investigators. Intensively loweringboth low-density lipoprotein cholesterol and blood pressure dose not reduce cardiovascular risk in Japanese coronary artery disease patients. Circ J 2011; 75: 2062-2070.
-
(2011)
Circ J
, vol.75
, pp. 2062-2070
-
-
Kohro, T.1
Yamazaki, T.2
Izumi, T.3
Daida, H.4
Kurabayashi, M.5
Miyauchi, K.6
-
10
-
-
79952106340
-
Differential metabolic effects of distinct statins
-
Koh KK, Sakuma I, Quon MJ. Differential metabolic effects of distinct statins. Atherosclerosis 2011; 215: 1-8.
-
(2011)
Atherosclerosis
, vol.215
, pp. 1-8
-
-
Koh, K.K.1
Sakuma, I.2
Quon, M.J.3
-
11
-
-
84255172397
-
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in japanese patients: Justification for Atherosclerosis Regression Treatment (JART) Study
-
Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, et al. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in japanese patients: Justification for Atherosclerosis Regression Treatment (JART) Study. Circ J 2012; 76: 221-229.
-
(2012)
Circ J
, vol.76
, pp. 221-229
-
-
Nohara, R.1
Daida, H.2
Hata, M.3
Kaku, K.4
Kawamori, R.5
Kishimoto, J.6
-
12
-
-
84855833067
-
Caveats to aggressive lowering of lipids by specific statins
-
Koh KK, Lim S, Sakuma I, Quon MJ. Caveats to aggressive lowering of lipids by specific statins. Int J Cardiol 2012; 154: 97-101.
-
(2012)
Int J Cardiol
, vol.154
, pp. 97-101
-
-
Koh, K.K.1
Lim, S.2
Sakuma, I.3
Quon, M.J.4
-
13
-
-
67650738656
-
Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study
-
Kashima Y, Izawa A, Aizawa K, Koshikawa M, Kasai H, Tomita T, et al. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study. J Cardiol 2009; 54: 76-79.
-
(2009)
J Cardiol
, vol.54
, pp. 76-79
-
-
Kashima, Y.1
Izawa, A.2
Aizawa, K.3
Koshikawa, M.4
Kasai, H.5
Tomita, T.6
-
14
-
-
84877730804
-
How to control residual cardiovascular risk despite statin treatment: Focusing on HDL-cholesterol
-
2012 April 12, doi:10.1016/j.ijcard.2012.03.127
-
Lim S, Park YM, Sakuma I, Koh KK. How to control residual cardiovascular risk despite statin treatment: Focusing on HDL-cholesterol. Int J Cardiol 2012 April 12 [doi:10.1016/j.ijcard.2012.03.127].
-
Int J Cardiol
-
-
Lim, S.1
Park, Y.M.2
Sakuma, I.3
Koh, K.K.4
|